Deleterious mutations could soon be spotted on a DNA level. In a new study from the University of California, Santa Barbara, nanotechnology developers describe their new “DNA clamp” — a groundbreaking innovation that will facilitate the detection of minute genetic variations associated with adverse health outcomes. The technology stands to revolutionize the treatment and diagnosis of certain cancers and other diseases with a genetic basis.
Hey, check out all the engineering jobs. Post your resume today!
